These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1116309)

  • 1. Frequency of phenylketonuria in Norway.
    Saugstad LF
    Clin Genet; 1975 Jan; 7(1):40-51. PubMed ID: 1116309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthropological significance of phenylketonuria.
    Saugstad LF
    Clin Genet; 1975 Jan; 7(1):52-61. PubMed ID: 803884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKU mutations R408Q and F299C in Norway: haplotype associations, geographic distributions and phenotype characteristics.
    Eiken HG; Stangeland K; Skjelkvåle L; Knappskog PM; Boman H; Apold J
    Hum Genet; 1992 Mar; 88(6):608-12. PubMed ID: 1312992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The frequency of PKU and hyperphenylalaninemia in Sweden - a study in institutions for the mentally retarded as well as in neonates.
    Holmgren G; Larsson A; Palmstierna H; Alm J
    Clin Genet; 1976 Dec; 10(6):313-8. PubMed ID: 991440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening programme for phenylketonuria in the Gaza Strip: evaluation and recommendations.
    Abu Shahla AN; Abed Y; Abu Shahla NK
    J Trop Pediatr; 2004 Apr; 50(2):101-5; discussion 106. PubMed ID: 15088800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylketonuria in Kuwait and Arab countries.
    Teebi AS; Al-Awadi SA; Farag TI; Naguib KK; el-Khalifa MY
    Eur J Pediatr; 1987 Jan; 146(1):59-60. PubMed ID: 3582406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular phenylalanine and tyrosine concentration in homozygotes and heterozygotes for phenylketonuria (PKU) and hyperphenylalaninemia compared with normals.
    Thalhammer O; Lubec G; Königshofer H; Scheibenreiter S; Coradello H
    Hum Genet; 1982; 60(4):320-1. PubMed ID: 7106768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment and control of patients with phenylketonuria: results from the Collaborative Group of Spanish Follow-up Units].
    Campistol J; González MJ; Gutiérrez AP; Vilaseca MA;
    Med Clin (Barc); 2012 Mar; 138(5):185-91. PubMed ID: 21794880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [15 years of national screening for phenylketonuria in The Netherlands; 4th Report of the National Commission for Management of Phenylketonuria].
    Verkerk PH; Vaandrager GJ; Sengers RC
    Ned Tijdschr Geneeskd; 1990 Dec; 134(52):2533-6. PubMed ID: 2270129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of phenylketonuria in Thailand.
    Kietduriyakul V; Komkris V; Tongkittikul K; Leangphibul P
    J Med Assoc Thai; 1989 Sep; 72(9):516-9. PubMed ID: 2809457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylketonuria genotypes correlated to metabolic phenotype groups in Norway.
    Eiken HG; Knappskog PM; Motzfeldt K; Boman H; Apold J
    Eur J Pediatr; 1996 Jul; 155(7):554-60. PubMed ID: 8831077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria.
    Burton BK; Jones KB; Cederbaum S; Rohr F; Waisbren S; Irwin DE; Kim G; Lilienstein J; Alvarez I; Jurecki E; Levy H
    Mol Genet Metab; 2018 Nov; 125(3):228-234. PubMed ID: 30266197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [20-year national screening for phenylketonuria in The Netherlands. National Guidance Commission PKU].
    Verkerk PH
    Ned Tijdschr Geneeskd; 1995 Nov; 139(45):2302-5. PubMed ID: 7501062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of classical phenylketonuria in mentally retarded individuals in Iran.
    Ghiasvand NM; Aledavood A; Ghiasvand R; Seyedin Borojeny F; Aledavood AR; Seyed S; Miner W; Saeb Taheri GR
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S283-7. PubMed ID: 19768570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of the phenylketonuria screening programme in Estonia.
    Ounap K; Lilleväli H; Metspalu A; Lipping-Sitska M
    J Med Screen; 1998; 5(1):22-3. PubMed ID: 9575455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classic phenylketonuria: diagnosis through heterozygote detection.
    Griffin RF; Elsas LJ
    J Pediatr; 1975 Apr; 86(4):512-7. PubMed ID: 1127497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular concentrations of phenylalanine, tyrosine and alpha-aminobutyric acid in 13 homozygotes and 19 heterozygotes for phenylketonuria (PKU) compared with 26 normals.
    Thalhammer O; Pollak A; Lubec G; Königshofer H
    Hum Genet; 1980; 54(2):213-6. PubMed ID: 7390492
    [No Abstract]   [Full Text] [Related]  

  • 18. [Did the change of technique of screening investigations influence on improvement of test credibility in recognizing and differentiating diagnostics of hiperphenylalaninemias?].
    Didycz B; Lemańska D; Słuszniak A
    Przegl Lek; 2009; 66(1-2):11-3. PubMed ID: 19485249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylketonuria is still a major cause of mental retardation in Tunisia despite the possibility of treatment.
    Khemir S; El Asmi M; Sanhaji H; Feki M; Jemaa R; Tebib N; Dhondt JL; Ben Dridi MF; Mebazaa A; Kaabachi N
    Clin Neurol Neurosurg; 2011 Nov; 113(9):727-30. PubMed ID: 21862209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylketonuria: variable phenotypic outcomes of the R261Q mutation and maternal PKU in the offspring of a healthy homozygote.
    Kleiman S; Vanagaite L; Bernstein J; Schwartz G; Brand N; Elitzur A; Woo SL; Shiloh Y
    J Med Genet; 1993 Apr; 30(4):284-8. PubMed ID: 8487271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.